199 related articles for article (PubMed ID: 28521255)
1. Pharmacokinetics of ketamine and norketamine enantiomers after racemic or S-ketamine IV bolus administration in dogs during sevoflurane anaesthesia.
Romagnoli N; Bektas RN; Kutter AP; Barbarossa A; Roncada P; Hartnack S; Bettschart-Wolfensberger R
Res Vet Sci; 2017 Jun; 112():208-213. PubMed ID: 28521255
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of S-ketamine and R-ketamine and their active metabolites after racemic ketamine or S-ketamine intravenous administration in dogs sedated with medetomidine.
Romagnoli N; Bektas RN; Kutter APN; Barbarossa A; Roncada P; Hartnack S; Bettschart-Wolfensberger R
Vet Anaesth Analg; 2020 Mar; 47(2):168-176. PubMed ID: 31973916
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration during isoflurane anaesthesia in Shetland ponies.
Larenza MP; Landoni MF; Levionnois OL; Knobloch M; Kronen PW; Theurillat R; Schatzmann U; Thormann W
Br J Anaesth; 2007 Feb; 98(2):204-12. PubMed ID: 17218377
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of ketamine and three metabolites in Beagle dogs under sevoflurane vs. medetomidine comedication assessed by enantioselective capillary electrophoresis.
Sandbaumhüter FA; Theurillat R; Bektas RN; Kutter APN; Bettschart-Wolfensberger R; Thormann W
J Chromatogr A; 2016 Oct; 1467():436-444. PubMed ID: 27485149
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of ketamine and its metabolite, norketamine, after intravenous administration of a bolus of ketamine to isoflurane-anesthetized dogs.
Pypendop BH; Ilkiw JE
Am J Vet Res; 2005 Dec; 66(12):2034-8. PubMed ID: 16379643
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective pharmacokinetics of ketamine and norketamine after constant rate infusion of a subanesthetic dose of racemic ketamine or S-ketamine in Shetland ponies.
Larenza MP; Peterbauer C; Landoni MF; Levionnois OL; Schatzmann U; Spadavecchia C; Thormann W
Am J Vet Res; 2009 Jul; 70(7):831-9. PubMed ID: 19566468
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome.
Goldberg ME; Torjman MC; Schwartzman RJ; Mager DE; Wainer IW
Pain Physician; 2010; 13(4):379-87. PubMed ID: 20648207
[TBL] [Abstract][Full Text] [Related]
8. The effect of route of administration on the enantioselective pharmacokinetics of ketamine and norketamine in rats.
Le Nedelec M; Glue P; Winter H; Goulton C; Medlicott NJ
J Psychopharmacol; 2018 Oct; 32(10):1127-1132. PubMed ID: 29895202
[TBL] [Abstract][Full Text] [Related]
9. S-ketamine and s-norketamine plasma concentrations after nasal and i.v. administration in anesthetized children.
Weber F; Wulf H; Gruber M; Biallas R
Paediatr Anaesth; 2004 Dec; 14(12):983-8. PubMed ID: 15601346
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ketamine and its major metabolites norketamine, hydroxynorketamine, and dehydronorketamine: a model-based analysis.
Kamp J; Jonkman K; van Velzen M; Aarts L; Niesters M; Dahan A; Olofsen E
Br J Anaesth; 2020 Nov; 125(5):750-761. PubMed ID: 32838982
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective pharmacokinetics of (R)- and (S)-ketamine after a 5-day infusion in patients with complex regional pain syndrome.
Goldberg ME; Torjman MC; Schwartzman RJ; Mager DE; Wainer IW
Chirality; 2011 Feb; 23(2):138-43. PubMed ID: 20803495
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ketamine following a short intravenous infusion to isoflurane-anesthetized New Zealand White rabbits (Oryctolagus cuniculus).
Luca GC; Barter LS; Pypendop BH
Vet Anaesth Analg; 2020 May; 47(3):334-340. PubMed ID: 32222343
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration in Shetland ponies sedated with xylazine.
Larenza MP; Knobloch M; Landoni MF; Levionnois OL; Kronen PW; Theurillat R; Schatzmann U; Thormann W
Vet J; 2008 Sep; 177(3):432-5. PubMed ID: 17604192
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing.
Fanta S; Kinnunen M; Backman JT; Kalso E
Eur J Clin Pharmacol; 2015 Apr; 71(4):441-7. PubMed ID: 25724645
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horses.
Lankveld DP; Driessen B; Soma LR; Moate PJ; Rudy J; Uboh CE; van Dijk P; Hellebrekers LJ
J Vet Pharmacol Ther; 2006 Dec; 29(6):477-88. PubMed ID: 17083451
[TBL] [Abstract][Full Text] [Related]
16. Rifampicin has a profound effect on the pharmacokinetics of oral S-ketamine and less on intravenous S-ketamine.
Peltoniemi MA; Saari TI; Hagelberg NM; Laine K; Kurkinen KJ; Neuvonen PJ; Olkkola KT
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):325-32. PubMed ID: 22676424
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the stereoselective biotransformation of ketamine to norketamine via determination of their enantiomers in equine plasma by capillary electrophoresis.
Theurillat R; Knobloch M; Levionnois O; Larenza P; Mevissen M; Thormann W
Electrophoresis; 2005 Oct; 26(20):3942-51. PubMed ID: 16167314
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous lidocaine, ketamine, and the combination on the minimum alveolar concentration of sevoflurane in dogs.
Wilson J; Doherty TJ; Egger CM; Fidler A; Cox S; Rohrbach B
Vet Anaesth Analg; 2008 Jul; 35(4):289-96. PubMed ID: 18363578
[TBL] [Abstract][Full Text] [Related]
19. Modeling the norketamine metabolite in children and the implications for analgesia.
Herd DW; Anderson BJ; Holford NH
Paediatr Anaesth; 2007 Sep; 17(9):831-40. PubMed ID: 17683400
[TBL] [Abstract][Full Text] [Related]
20. Subchronic administration of (R,S)-ketamine induces ketamine ring hydroxylation in Wistar rats.
Moaddel R; Sanghvi M; Ramamoorthy A; Jozwiak K; Singh N; Green C; O'Loughlin K; Torjman M; Wainer IW
J Pharm Biomed Anal; 2016 Aug; 127():3-8. PubMed ID: 27017097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]